LMAT (STOCKS)
LeMaitre Vascular, Inc.
$91.920000
-0.040000 (-0.04%)
Prev close: $91.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- George W. LeMaitre
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,100.44M
- Employees
- 664
- P/E (TTM)
- 33.87
- P/B (TTM)
- 5.16
- Dividend Yield
- 97.91%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $256.28M |
| Benefits Costs and Expenses | $175.67M |
| Cost Of Revenue | $70.77M |
| Costs And Expenses | $175.67M |
| Gross Profit | $185.52M |
| Operating Expenses | $112.45M |
| Research and Development | $14.10M |
| Other Operating Expenses | $98.35M |
| Operating Income/Loss | $73.06M |
| Income/Loss From Continuing Operations After Tax | $62.40M |
| Income/Loss From Continuing Operations Before Tax | $80.62M |
| Income Tax Expense/Benefit | $18.21M |
| Net Income/Loss | $62.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $62.40M |
| Net Income/Loss Available To Common Stockholders, Basic | $62.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.76 |
| Diluted Earnings Per Share | $2.71 |
| Basic Average Shares | 68,098,000 |
| Diluted Average Shares | 70,329,000 |
| Assets | $629.53M |
| Current Assets | $477.82M |
| Noncurrent Assets | $151.71M |
| Fixed Assets | $28.54M |
| Intangible Assets | $31.67M |
| Other Non-current Assets | $91.49M |
| Liabilities | $222.90M |
| Current Liabilities | $33.37M |
| Accounts Payable | $4.18M |
| Wages | $10.29M |
| Other Current Liabilities | $18.90M |
| Noncurrent Liabilities | $189.54M |
| Equity | $406.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $406.62M |
| Liabilities And Equity | $629.53M |
| Net Cash Flow From Operating Activities | $87.31M |
| Net Cash Flow From Operating Activities, Continuing | $87.31M |
| Net Cash Flow From Investing Activities | -$73.74M |
| Net Cash Flow From Investing Activities, Continuing | -$73.74M |
| Net Cash Flow From Financing Activities | -$12.52M |
| Net Cash Flow From Financing Activities, Continuing | -$12.52M |
| Net Cash Flow | $1.04M |
| Net Cash Flow, Continuing | $1.04M |
| Comprehensive Income/Loss | $61.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $63.70M |
| Other Comprehensive Income/Loss | $47.76M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.30M |